EyePoint (EYPT) Gross Profit (2018 - 2026)
EyePoint's Gross Profit was $507,000 in Q2 2026, down 90.2% from $5.17 million a year earlier but up 201.8% from the prior quarter.
Powered by 
Analysis
EyePoint (EYPT) Gross Profit (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, EyePoint's Gross Profit was $1.17 million through Jun 30, 2026, down 97.6% year-over-year; for FY2025, it came in at $29.31 million, down 25.9% from FY2024.
- Gross Profit shows a five-year compound annual growth rate of 0.5% (FY2020 to FY2025).
- In earlier years, Gross Profit was $39.56 million in FY2024 (-4.4%), $41.39 million in FY2023 (+25.1%), $33.08 million in FY2022 (+15.0%) and $28.76 million in FY2021 (+0.5%).
- Quarterly Gross Profit has moved between $168,000 (Q1 2026) and $23.65 million (Q1 2025) over five years.
- Compared with a year earlier, Gross Profit has declined for five straight quarters, with an average decline of 44.0% over the last eight quarters.
- The best year-over-year quarter for Gross Profit over five years was Q1 2025 (growth of 116.5%); the worst was Q1 2026 (a decline of 99.3%).
- Per Business Quant data, EYPT's Gross Profit in the three quarters before Q2 2026 was $168,000 (Q1 2026), $245,000 (Q4 2025) and $245,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | EyePoint | 277.89 Mn | -635.23 Mn | 507,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 507,000.00 |
| Mar 31, 2026 | 168,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Sep 30, 2025 | 245,000.00 |
| Jun 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 23.65 Mn |
| Dec 31, 2024 | 10.77 Mn |
| Sep 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Mar 31, 2024 | 10.93 Mn |
| Dec 31, 2023 | 13.03 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 7.31 Mn |
| Mar 31, 2023 | 7.04 Mn |
| Dec 31, 2022 | 7.12 Mn |
| Sep 30, 2022 | 8.61 Mn |
| Jun 30, 2022 | 9.83 Mn |
| Mar 31, 2022 | 7.52 Mn |
| Dec 31, 2021 | 8.51 Mn |
| Sep 30, 2021 | 7.23 Mn |
API Access
EyePoint Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=EYPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "EYPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=EYPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();